- Home
- AEHL vs CODX Comparison
AEHL vs CODX Comparison
Compare AEHL & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- CODX
- Stock Information
- Founded
- AEHL 1993
- CODX 2013
- Country
- AEHL China
- CODX United States
- Employees
- AEHL N/A
- CODX N/A
- Industry
- AEHL Building Materials
- CODX Medical/Dental Instruments
- Sector
- AEHL Industrials
- CODX Health Care
- Exchange
- AEHL Nasdaq
- CODX Nasdaq
- Market Cap
- AEHL 8.5M
- CODX 9.8M
- IPO Year
- AEHL 2007
- CODX 2017
- Fundamental
- Price
- AEHL $2.75
- CODX $0.27
- Analyst Decision
- AEHL
- CODX Buy
- Analyst Count
- AEHL 0
- CODX 2
- Target Price
- AEHL N/A
- CODX $5.50
- AVG Volume (30 Days)
- AEHL 123.4K
- CODX 491.4K
- Earning Date
- AEHL 05-01-2025
- CODX 08-07-2025
- Dividend Yield
- AEHL N/A
- CODX N/A
- EPS Growth
- AEHL N/A
- CODX N/A
- EPS
- AEHL N/A
- CODX N/A
- Revenue
- AEHL $98,773,000.00
- CODX $3,497,583.00
- Revenue This Year
- AEHL N/A
- CODX N/A
- Revenue Next Year
- AEHL N/A
- CODX $42.11
- P/E Ratio
- AEHL N/A
- CODX N/A
- Revenue Growth
- AEHL 36.99
- CODX N/A
- 52 Week Low
- AEHL $1.79
- CODX $0.23
- 52 Week High
- AEHL $256.40
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- AEHL 53.14
- CODX 43.19
- Support Level
- AEHL $2.33
- CODX $0.26
- Resistance Level
- AEHL $2.75
- CODX $0.29
- Average True Range (ATR)
- AEHL 0.25
- CODX 0.02
- MACD
- AEHL 0.05
- CODX 0.00
- Stochastic Oscillator
- AEHL 69.70
- CODX 26.83
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.